Skip to main content
Suhayl Dhib-Jalbut, MD, Neurology, New Brunswick, NJ

Suhayl Samih Dhib-Jalbut MD

Neuroimmunology/Multiple Sclerosis


Professor and Chairman, Department of Neurology, Rutgers-RWJ Medical School and New Jersey Medical School

Join to view full profile
  • 125 Paterson StSuite 6100New Brunswick, NJ 08901

  • Phone+1 732-235-7733

  • Fax+1 732-235-7041

Dr. Dhib-Jalbut is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Suhayl Dhib-Jalbut is a distinguished neurologist based in New Brunswick, NJ, specializing in neuroimmunology and multiple sclerosis. He completed his medical education at the American University of Beirut, his neurology residency at the University of Cincinnati and a Neuroimmunology/Multiple Sclerosis fellowship at the NIH. He held multiple positions including Senior Vice President at RWJBH, Professor with tenure and Chairman at Rutgers Robert Wood Johnson Medical School and New Jersey Medical School, and Chief at Robert Wood Johnson University Hospital. His previous roles include being an attending physician and consultant at both the University of Maryland Medical Center and the Baltimore Veterans Center. He had served as president of the Americas Committee for Treatment and Research in MS (ACTRIMS). He is currently a tenured professor and the Ruth Dunietz Kushner and Michael Jay Serwitz Chair in Multiple Sclerosis at Rutgers. His research is focused on multiple sclerosis funded by the NIH, NMSS, and industry. His work has been recognized through various awards, including the Medical Excellence Award from the National MS Society, the Edward J. Ill Excellence in Medicine Award, CMS Meaningful Use Certifications and Honorary Alumnus of Rutgers-RWJMS.

Education & Training

  • National Institutes of Health
    National Institutes of HealthSr. Staff Fellow, Neuroimmunology & Multiple Sclerosis, AOA, 1985 - 1990
  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 1981 - 1985
  • American University of Beirut
    American University of BeirutB.S., 1976 - 1980
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 1980

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2003 - 2027
  • MD State Medical License
    MD State Medical License 1986 - 2008
  • OH State Medical License
    OH State Medical License 1984 - 1992
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2012-2017
  • CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2012-2017
  • CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2012-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Current use of biomarkers to guide MS therapies  
    Dhib-Jalbut SS, IJMSC, 10/1/2013
  • From emerging agents to biomarkers: Integrating scientific advances into MS management  
    Dhib-Jalbut SS, Markowitz CE, Miller A, IJMSC, 1/1/2013
  • Immune response during Interferon-beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse free in the START study  
    Dhib-Jalbut SS, Sumandeep S, Valenzuela RM, Ito K, Patel P, Rametta M, J Neuroimmunol, 1/1/2013

Lectures

  • Minimizing Risks and Maximizing Efficacy for Management of Multiple Sclerosis 
    CMEducation Resources, LLC, San Jose, California - 4/20/2013
  • Minimizing Risks and Maximizing Efficacy for Management of Multiple Sclerosis 
    CMEducation Resources, LLC, Dallas, Texas - 4/13/2013
  • Minimizing Risks and Maximizing Efficacy for Management of Multiple Sclerosis 
    CMEducation Resources, LLC, Atlanta, Georgia - 4/6/2013

Press Mentions

  • RWJBarnabas Health Stroke Centers Recognized by American Heart Association, U.S. News & World Report Best Hospitals
    RWJBarnabas Health Stroke Centers Recognized by American Heart Association, U.S. News & World Report Best HospitalsAugust 6th, 2025
  • Aug 5, 2025 RWJBarnabas Health Stroke Centers Achieve National Recognition from American Heart Association, U.S. News & World Report Best Hospitals for 2025–26
    Aug 5, 2025 RWJBarnabas Health Stroke Centers Achieve National Recognition from American Heart Association, U.S. News & World Report Best Hospitals for 2025–26August 5th, 2025
  • Cooperman Barnabas Medical Center Achieves Highest Level of Stroke Certification from the Joint Commission
    Cooperman Barnabas Medical Center Achieves Highest Level of Stroke Certification from the Joint CommissionFebruary 20th, 2025

Grant Support

  • Effect of dysbiotic gut microbiota on the transport of short-chain fatty acids: Relevance to autoimmune disordersRUTGERS BIOMEDICAL AND HEALTH SCIENCES2024–2026
  • Bdnf-Engineered Stem Cell Mediated Neuroprotection In EAENational Institute Of Neurological Disorders And Stroke2009–2010
  • Interferon-B And Copolymer-I In Multiple Sclerosis.National Institute Of Neurological Disorders And Stroke2003
  • Interferon-B And Copolymer-I In Multiple Sclerosis.National Institute Of Neurological Disorders And Stroke1999–2002
  • Regulation &Function Of Class-Ii HLA Molecules In Measles Infected Human GliaNational Institute Of Neurological Disorders And Stroke1992–1996

Committees

  • Member, ASENT Program Committee 2019 - Present
  • Member, Data Safety Monitoring Board-NIAID 2010 - Present

Professional Memberships

Other Languages

  • Arabic

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: